Riskpilot← Back to searchSign inGet full accessMSK KLINIKKEN AS
ASActiveOrg 996385493Farmanns Gate 2, 1607 FredrikstadPhysiotherapy activities · NACE 8695Est. 20112 employeeswww.mskklinikken.no
Revenue 2024
NOK 4,2M
+7% vs 2023
EBITDA margin
-3.3%
-304% vs 2023
Equity ratio
-45.0%
Financial strength
Net profit 2024
NOK -156K
-395% vs 2023
| Revenue | NOK 4,2M | +7% |
| EBITDA | NOK -141K | -304% |
| Net profit | NOK -156K | -395% |
| Total assets | NOK 343K | +25% |
| Equity | NOK -154K | -10378% |
| Employees | 2 | — |
Legal name
MSK KLINIKKEN AS
Org number
996385493
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
8. januar 2011
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive fysioterapi- og manuellterapivirksomhet og annen virksomhet som naturlig drives i tilknytning til dette. I tillegg kan selskapet drive med investering i aksjer, fast eiendom og andre formuesgjenstander.
Address
Farmanns Gate 2, 1607 Fredrikstad
Website
www.mskklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 685 | 3 221 | 3 812 | 3 935 | 4 217 |
| Staff expenses | −1 128 | −1 459 | −1 415 | −1 551 | −1 808 |
| EBITDA | −72 | −57 | 221 | 69 | −141 |
| Depreciation & amort. | −13 | −12 | −12 | −13 | −5 |
| EBIT | −85 | −69 | 209 | 56 | −147 |
| Net financials | −8 | −8 | −6 | −3 | −9 |
| Profit before tax | −92 | −77 | 203 | 53 | −156 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −92 | −77 | 203 | 53 | −156 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 437 | 338 | 330 | 275 | 343 |
| Equity | −178 | −254 | −51 | 2 | −154 |
| Long-term debt | 243 | 173 | 101 | 26 | 177 |
| Short-term debt | 371 | 420 | 281 | 248 | 321 |
| Total debt | 614 | 592 | 381 | 274 | 498 |
EBITDA margin
-3.3%
This company
15.8%
Market median
-121% vs market
20202024
Equity ratio
-45.0%
This company
38.2%
Market median
-218% vs market
20202024
Return on equity
-15587400.0%
This company
18.4%
Market median
-84714230% vs market
20202024
Net profit margin
-3.7%
This company
8.1%
Market median
-146% vs market
20202024
Asset turnover
12.29×
This company
1.12×
Market median
+997% vs market
20202024
Debt / equity
3.22×
This company
0.62×
Market median
-419% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SE Chief Executive Officer | Chief Executive Officer | 2011 |
MS Deputy Member | Deputy Member | 2011 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MSK KLINIKKEN AS 
RASKERE STERKERE HØYERE ASBoard members of MSK KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svein Erik Kristiansen | Chief Executive Officer | 0 companies |
| Maria Suzanne Kristiansen | Deputy Member | 0 companies |